跳至主要内容
临床试验/NCT01902212
NCT01902212已完成不适用

Evaluation of an Oral Nutrition Supplement

Abbott Nutrition2 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2013年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
25
试验地点
2
主要终点
Gastro-Intestinal Tolerance

研究概览

简要总结

The objective of this study is to capture gastrointestinal tolerance (GI) information on a nutrient dense oral nutritional supplement (ONS) in healthy elderly subjects.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
盲法
None

入排标准

年龄范围
60 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects will be eligible for the study if they meet all of the following inclusion criteria:
  • Male or female ≥ 60 and ≤ 90 years of age.
  • Body Mass Index (BMI) > 20 but < 35.

排除标准

  • Subjects will be excluded from the study if they meet any of the following criteria:
  • History of diabetes
  • Antibiotic use within 1 week prior to enrollment
  • Undergone major surgery less than 3 months prior to enrollment.
  • Current active malignant disease or was treated within the last 6 months for cancer.
  • Immunodeficiency disorder.
  • Myocardial infarction within the last 3 months.
  • Chronic obstructive pulmonary disease (COPD).
  • Allergy to any of the ingredients in the study product.
  • Obstruction of the gastrointestinal tract or other major gastrointestinal disease.
  • Dementia, brain metastases, eating disorders, history of significant neurological or psychiatric disorder.
  • Unintentional weight loss or weight gain ≥ 5% in last 4 weeks.
  • Taking medications/dietary supplements/substances that could profoundly modulate metabolism or affect GI motility.

结局指标

主要结局

Gastro-Intestinal Tolerance

时间窗: Study Day (SD) 1-8

Subject questionnaire

次要结局

  • ONS Consumption(SD 1-8)
  • Weight(Screening and SD 8)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验